Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan

Gut Microbes

Volumn 9, Issue 2, 2018, Pages 93-101

  Harris, Vanessa ^a   Ali, Asad ^b   Fuentes, Susana ^b   Korpela, Katri ^c,d   Kazi, Momin ^b   Tate, Jacqueline ^e   Parashar, Umesh ^e   Wiersinga, W Joost ^a   Giaquinto, Carlo ^f   de Weerth, Carolina ^g   de Vos, Willem M ^c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^f UNIVERSITY OF PADOVA   (Italy)

^g RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

intestinal microbes; rotavirus vaccine; seroconversion; vaccine immunogenicity

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; ROTAVIRUS VACCINE; IMMUNOGLOBULIN A; VIRUS ANTIBODY;

ARTICLE; BREAST FEEDING; CASE CONTROL STUDY; CONTROLLED STUDY; DNA HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GAMMAPROTEOBACTERIA; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOGENICITY; INFANT; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PHASE 4 CLINICAL TRIAL; PHYLOGENY; PILOT STUDY; ROTAVIRUS INFECTION; SERRATIA; VACCINATION; VAGINAL DELIVERY; BACTERIUM; BLOOD; CLASSIFICATION; FECES; GASTROENTERITIS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PAKISTAN; ROTAVIRUS; VIROLOGY;

ANTIBODIES, VIRAL; BACTERIA; CASE-CONTROL STUDIES; FECES; FEMALE; GASTROENTERITIS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOGLOBULIN A; INFANT; MALE; PAKISTAN; PHYLOGENY; PILOT PROJECTS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 85030166240     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2017.1376162     Document Type: Article

References (48)

1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:136-41. doi:10.1016/S1473-3099(11)70253-5.
2. Bar-Zeev N, Kapanda L, Tate JE, Khuzwayo CJ, Iturriza-Gomez M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS a, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis. 2015;15:422-8. doi:10.1016/S1473-3099(14)71060-6.
3. Abeid KA, Jani B, Cortese MM, Kamugisha C, Mwenda JM, Pandu AS, Msaada KA, Mohamed AS, Khamis AU, Parashar UD, et al. Monovalent Rotavirus Vaccine effectiveness and impact on rotavirus hospitalizations in Zanzibar, Tanzania: data from the first 3 years after introduction. J Infect Dis. 2016;jiw524. doi:10.1093/infdis/jiw524.
4. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22. doi:10.1056/NEJMoa052434.
5. Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371:1181-9.doi:10.1016/S0140-6736(08)60524-3.
6. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757-63. doi:10.1016/S0140-6736(07)61744-9.
7. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33. doi:10.1056/NEJMoa052664.
8. Fischer Walker CL, Black RE. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health. 2011;11 Suppl 3:S16. doi:10.1186/1471-2458-11-S3-S16.
9. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606-14. doi:10.1016/S0140-6736(10)60889-6.
10. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289-98. doi:10.1056/NEJMoa0904797.
11. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TPM, Luby SP, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:615-23. doi:10.1016/S0140-6736(10)60755-6.
12. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:2136-43. doi:10.1016/S0140-6736(13)62630-6.
13. Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. J Infect Dis. 2009;200 Suppl 1:S28-38. doi:10.1086/605033.
14. Emperador DM, Velasquez DE, Estivariz CF, Ben, Lopman, Jiang B, Parashar U, Anand A, Zaman K. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh. Clin Infect Dis. 2016;62:150-6. doi:10.1093/cid/civ807.
15. Moon S-S, Groome MJ, Velasquez DE, Parashar UD, Jones S, Koen A, van Niekerk N, Jiang B, Madhi SA. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants. Clin Infect Dis. 2016;62:157-65. doi:10.1093/cid/civ828.
16. Chilengi R, Simuyandi M, Beach L, Mwila K, Becker-Dreps S, Emperador DM, Velasquez DE, Bosomprah S, Jiang B. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants. PLoS ONE. 2016;11(3) 11:e0150100. doi:10.1371/journal.pone.0150100.
17. Nordgren J, Sharma S, Bucardo F, Nasir W, Gunayd n G, Ouermi D, Nitiema LW, Becker-Dreps S, Simpore J, Hammarstrom L, et al. Both Lewis and Secretor Status Mediate Susceptibility to Rotavirus Infections in a Rotavirus Genotype-Dependent Manner. Clin Infect Dis. 2014;59(11):1567-73. doi:10.1093/cid/ciu633.
18. Ali A, Kazi AM, Cortese MM, Fleming JA, Moon S, Parashar UD, Jiang B, Mcneal MM, Steele D, Bhutta Z, et al. Impact of Withholding Breastfeeding at the Time of Vaccination on the Immunogenicity of Oral Rotavirus Vaccine—A Randomized Trial. PLoS ONE. 2015;10: e0127622. doi:10.1371/journal.pone.0127622.
19. Ali SA, Kazi AM, Cortese MM, Fleming JA, Parashar UD, Jiang B, McNeal MM, Steele D, Bhutta Z, Zaidi A. Impact of Different Dosing Schedules on the Immunogenicity of the Human Rotavirus Vaccine in Infants in Pakistan: A Randomized Trial. J Infect Dis. 2014 Dec 1;210(11):1772-9. doi:10.1093/infdis/jiu335.
20. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222-7. doi:10.1038/nature11053.
21. Harris VC, Armah G, Fuentes S, Korpela KE, Parashar U, Victor JC, Tate J, de Weerth C, Giaquinto C, Wiersinga WJ, et al. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana. J Infect Dis. 2017;2017Jan1;215(1):34-41. doi:10.1093/infdis/jiw518.
22. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine. 2003;13:310-2. doi:10.1016/0264-410X(95)93319-5.
23. Zhang B, Chassaing B, Shi Z, Uchiyama R, Zhang Z, Denning TL, Crawford SE, Pruijssers AJ, Iskarpatyoti JA, Estes MK, et al. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science. 2014;346:861-5. doi:10.1126/science.1256999.
24. Vatanen T, Kostic AD, d'Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R, Vlamakis H, Arthur TD, Hämäläinen A-M, et al. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell. 2016;165:842-53. doi:10.1016/j.cell.2016.04.007.
25. Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res. 2001;7:167-202.
26. Shin N-R, Whon TW, Bae J-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015 Sep;33(9):496-503.doi:10.1016/j.tibtech.2015.06.011.
27. Rudin A, Lundell A-C. Infant B cell memory and gut bacterial colonization. Gut Microbes. 2014;3:474-5. doi:10.4161/gmic.21419.
28. J Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, Gonzalez-Hernandez MB, Iovine NM, Wobus CE, Vinje J, et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science. 2014;346:755-9. doi:10.1126/science.1257147.
29. Wacklin P, Tuimala J, Nikkilä J, Sebastian, Tims, Mäkivuokko H, Alakulppi N, Laine P, Rajilić-Stojanović M, Paulin L, De Vos WM, et al. Faecal Microbiota Composition in Adults Is Associated with the FUT2 Gene Determining the Secretor Status. PLoS ONE. 2014;2014Apr14;9(4):e94863. doi:10.1371/journal.pone.0094863.
30. Payne DC, Currier RL, Staat MA, Sahni LC, Selvarangan R, Halasa NB, Englund JA, Weinberg GA, Boom JA, Szilagyi PG, et al. Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr. 2015;69(11):1040-5. doi:10.1001/jamapediatrics.2015.2002.
31. Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A Systematic Review of Anti-Rotavirus Serum IgA Antibody Titer as a Potential Correlate of Rotavirus Vaccine Efficacy. J Infect Dis. 2013;208:284-94. doi:10.1093/infdis/jit166.
32. de Weerth C, Fuentes S, Puylaert P, De Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics. 2013;131:e550-8. doi:10.1542/peds.2012-1449.
33. Zijlmans MAC, Korpela K, Riksen-Walraven JM, De Vos WM, de Weerth C. Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology. 2015;53:233-45. doi:10.1016/j.psyneuen.2015.01.006.
34. Bernstein DI, Smith VE, Sherwood JR, Schiff GM, Sander DS, DeFeudis D, Spriggs DR, Ward RL. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89–12. Vaccine. 1997;16:381-7. doi:10.1016/S0264-410X(97)00210-7.
35. Salonen A, Nikkilä J, Jalanka-Tuovinen J, Immonen O, Rajilić-Stojanović M, Kekkonen RA, Palva A, De Vos WM. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: Effective recovery of bacterial and archaeal DNA using mechanical cell lysis, J Microbiol Methods. 2010;81(2):127-34. doi: 10.1016/j.mimet.2010.02.007.
36. Rajilić-Stojanović M, Heilig HGHJ, Molenaar D, Kajander K, Surakka A, Smidt H, De Vos WM. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol. 2009;11:1736-51. doi:10.1111/j.1462-2920.2009.01900.x.
37. Lahti L, Salojärvi J, Salonen A, Scheffer M, De Vos WM. Tipping elements in the human intestinal ecosystem. Nat Commun. 2014;5:59. doi:10.1038/ncomms5344.
38. Lahti L, Torrente A, Elo LL, Brazma A, Rung J. A fully scalable online pre-processing algorithm for short oligonucleotide microarray atlases. Nucleic Acids Research. 2013;41:e110-0. doi:10.1093/nar/gkt229.
39. Claesson MJ, O'Sullivan O, Wang Q, Nikkilä J, Marchesi JR, Smidt H, De Vos WM, Ross RP, O'toole PW. Comparative Analysis of Pyrosequencing and a Phylogenetic Microarray for Exploring Microbial Community Structures in the Human Distal Intestine. PLoS ONE. 2009;2009Aug20;4(8):e6669. doi:10.1371/journal.pone.0006669.
40. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174-80. doi:10.1038/nature09944.
41. Leps J, Smilauer P. Multivariate Analysis of Ecological Data Using CANOCO [Internet]. Cambridge:Cambridge University Press;2003. Available from: http://www.cambridge.org/9780521814096.
42. Korpela K., Mare: Microbiota analysis in R Easily. R Package version 1.0. 2016. Available from https://github.com/katrikorpela/mare
43. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 2011. Available from http://www.R-project.org/
44. Pinheiro JC, Bates D, DebRoy S, Sarkar D, and R Core Team. nlme: Linear and Nonlinear Mixed Effects Models. R package version. 2016;3:1-128.
45. Venables WN, Ripley BD. Modern Applied Statistics with S. Fourth Edition. New York:Springer; 2002.ISBN 0-387-95456-0.
46. Kampstra P. Beanplot: A Boxplot Alternative for Visual Comparison of Distributions. Journal of Statistical Software. 2008;Code Snippets 28 (1):1-9. URL http://www.jstatsoftsoft.org/v28/c01/.
47. Foster ZSL, Sharpton TJ, Grünwald NJ. Metacoder: An R package for visualization and manipulation of community taxonomic diversity data. PLoS Comput Biol. 2017;13(2):e1005404. doi:10.1371/journal.pcbi.1005404
48. Oksanen J, Guillaume Blanchet F, Friendly M, Kindt R, Legendre P, McGlinn D, Minchin PR, OHara RB, Gavin L, Simpson P, Solymos P., vegan: Community Ecology Package. Ordination methods, diversity analysis and other functions for community and vegetation ecologists. Version 2.4-0. Available from: https://CRAN.R-project.org/package=vegan.